Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001503 · ClinicalTrials.gov registry record
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,031
- Enrollment target
NCT00001503: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001503 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,031 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001503 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,031 participants
- Enrollment target
Study Summary
This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
Primary Outcome
Provision of a mechanism to follow selected CCR patients when their protocols have been terminated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,031 participants |
| Start Date | 1996-09-19 |
| Est. Completion | 2023-06-15 |
What the finished NCT00001503 record still lists
NCT00001503 is an observational study that tracks outcomes without assigning an intervention. Its 1,031 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001503 about?
NCT00001503 is a clinical study titled "Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease". This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
What is the current status of trial NCT00001503?
This trial is currently completed. The enrollment target is 1,031 participants. The study started on 1996-09-19. Estimated completion is 2023-06-15.
Who is sponsoring clinical trial NCT00001503?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI